Announcement • May 29
Shenzhen Noposion Crop Science Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 01 June 2026 Shenzhen Noposion Crop Science Co., Ltd. announced final cash dividend of CNY 3.00000000 per 10 A shares (tax included) for 2025. Record date: 29 May 2026; Ex-date: 01 June 2026 and Payment date: 01 June 2026. Reported Earnings • Apr 28
Full year 2025 earnings released: EPS: CN¥0.66 (vs CN¥0.59 in FY 2024) Full year 2025 results: EPS: CN¥0.66 (up from CN¥0.59 in FY 2024). Revenue: CN¥5.78b (up 9.3% from FY 2024). Net income: CN¥650.4m (up 11% from FY 2024). Profit margin: 11% (in line with FY 2024). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Apr 28
Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 20, 2026 Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China Announcement • Mar 31
Shenzhen Noposion Crop Science Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Buy Or Sell Opportunity • Mar 18
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at CN¥10.52. The fair value is estimated to be CN¥13.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 30% in 2 years. Earnings are forecast to grow by 115% in the next 2 years. Buy Or Sell Opportunity • Jan 13
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 8.4% to CN¥11.08. The fair value is estimated to be CN¥14.07, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 44% in 2 years. Earnings are forecast to grow by 117% in the next 2 years. Announcement • Dec 31
Shenzhen Noposion Crop Science Co., Ltd. to Report Fiscal Year 2025 Results on Apr 17, 2026 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report fiscal year 2025 results on Apr 17, 2026 Buy Or Sell Opportunity • Dec 29
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 16% to CN¥10.85. The fair value is estimated to be CN¥13.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 119% in the next 2 years. Buy Or Sell Opportunity • Dec 11
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to CN¥10.77. The fair value is estimated to be CN¥13.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 119% in the next 2 years. Buy Or Sell Opportunity • Nov 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to CN¥10.77. The fair value is estimated to be CN¥13.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 50% in 2 years. Earnings are forecast to grow by 119% in the next 2 years. Reported Earnings • Oct 29
Third quarter 2025 earnings released: CN¥0.073 loss per share (vs CN¥0.063 loss in 3Q 2024) Third quarter 2025 results: CN¥0.073 loss per share (further deteriorated from CN¥0.063 loss in 3Q 2024). Revenue: CN¥407.4m (down 18% from 3Q 2024). Net loss: CN¥72.5m (loss widened 12% from 3Q 2024). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 30% per year. Announcement • Sep 30
Shenzhen Noposion Crop Science Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 Reported Earnings • Aug 22
Second quarter 2025 earnings released: EPS: CN¥0.022 (vs CN¥0.10 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.022 (down from CN¥0.10 in 2Q 2024). Revenue: CN¥1.58b (flat on 2Q 2024). Net income: CN¥21.1m (down 78% from 2Q 2024). Profit margin: 1.3% (down from 6.2% in 2Q 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 28% per year. New Risk • Jul 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (52% net debt to equity). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.1% average weekly change). Announcement • Jul 02
Shenzhen Noposion Crop Science Co., Ltd. to Report First Half, 2025 Results on Aug 20, 2025 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report first half, 2025 results on Aug 20, 2025 Buy Or Sell Opportunity • Jun 18
Now 22% undervalued Over the last 90 days, the stock has risen 11% to CN¥10.76. The fair value is estimated to be CN¥13.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.0% over the last 3 years. Earnings per share has grown by 25%. Revenue is forecast to grow by 30% in 2 years. Earnings are forecast to grow by 66% in the next 2 years. Declared Dividend • May 28
Dividend increased to CN¥0.35 Dividend of CN¥0.35 is 133% higher than last year. Ex-date: 30th May 2025 Payment date: 30th May 2025 Dividend yield will be 2.9%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 96% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • May 26
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥11.21, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 98% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.43 per share. Announcement • May 22
Shenzhen Noposion Crop Science Co., Ltd. Approves Cash Dividend for 2024 Shenzhen Noposion Crop Science Co., Ltd. announced that at its AGM held on 16 May 2025, the shareholders approved 2024 profit distribution plan: cash dividend/10 shares (tax included) of CNY 3.50000000. Reported Earnings • Apr 25
First quarter 2025 earnings released: EPS: CN¥0.64 (vs CN¥0.46 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.64 (up from CN¥0.46 in 1Q 2024). Revenue: CN¥2.10b (up 15% from 1Q 2024). Net income: CN¥626.9m (up 38% from 1Q 2024). Profit margin: 30% (up from 25% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is expected to decline by 3.0% p.a. on average during the next 2 years, while revenues in the Chemicals industry in China are expected to grow by 15%. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Announcement • Apr 25
Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 16, 2025 Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China Price Target Changed • Apr 12
Price target increased by 17% to CN¥15.00 Up from CN¥12.77, the current price target is provided by 1 analyst. New target price is 70% above last closing price of CN¥8.81. Stock is up 13% over the past year. The company is forecast to post earnings per share of CN¥0.68 for next year compared to CN¥0.24 last year. Announcement • Mar 31
Shenzhen Noposion Crop Science Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥10.06, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 68% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.61 per share. Announcement • Dec 31
Shenzhen Noposion Crop Science Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥11.34, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.00 per share. Reported Earnings • Oct 29
Third quarter 2024 earnings released: CN¥0.063 loss per share (vs CN¥0.059 loss in 3Q 2023) Third quarter 2024 results: CN¥0.063 loss per share (further deteriorated from CN¥0.059 loss in 3Q 2023). Revenue: CN¥494.3m (down 3.5% from 3Q 2023). Net loss: CN¥64.6m (loss widened 12% from 3Q 2023). Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 17% per year. Announcement • Sep 30
Shenzhen Noposion Crop Science Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥9.01, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years. Reported Earnings • Aug 29
Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 2Q 2023). Revenue: CN¥1.57b (up 31% from 2Q 2023). Net income: CN¥97.9m (down 18% from 2Q 2023). Profit margin: 6.2% (down from 9.9% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Jul 11
Shenzhen Noposion Crop Science Co., Ltd. Announces Board Changes Shenzhen Noposion Crop Science Co., Ltd. at its 2nd Extraordinary General Meeting of 2024 on 09 July 2024 were approved; Xu Jia, independent director, Jiang Fan, independent director, Hu Tingting, supervisor, Sun Chengyan, supervisor. Announcement • Jun 29
Shenzhen Noposion Crop Science Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024 Declared Dividend • Jun 05
Dividend of CN¥0.15 announced Dividend of CN¥0.15 is the same as last year. Ex-date: 7th June 2024 Payment date: 7th June 2024 Dividend yield will be 1.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (48% earnings payout ratio) and cash flows (40% cash payout ratio). The dividend has increased by an average of 2.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 102% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • May 27
Shenzhen Noposion Crop Science Co., Ltd. Approves Cash Dividend for the Year 2023 Shenzhen Noposion Crop Science Co., Ltd. at its AGM held on May 23, 2024, approved cash dividend/10 shares (tax included) of CNY 1.50000000 for the year 2023. New Risk • May 16
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 16% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risk Paying a dividend despite having no free cash flows. Major Estimate Revision • May 09
Consensus EPS estimates fall by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.88b to CN¥4.68b. EPS estimate also fell from CN¥0.73 per share to CN¥0.655 per share. Net income forecast to grow 51% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥12.66. Share price was steady at CN¥8.83 over the past week. Announcement • Apr 29
Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 23, 2024 Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 23, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China Reported Earnings • Apr 03
Full year 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.34 in FY 2022) Full year 2023 results: EPS: CN¥0.24 (down from CN¥0.34 in FY 2022). Revenue: CN¥4.13b (down 3.1% from FY 2022). Net income: CN¥233.3m (down 29% from FY 2022). Profit margin: 5.6% (down from 7.7% in FY 2022). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 14% per year and the company’s share price has also increased by 14% per year. Announcement • Mar 30
Shenzhen Noposion Crop Science Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Buy Or Sell Opportunity • Feb 28
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to CN¥7.73. The fair value is estimated to be CN¥10.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings are forecast to grow by 162% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥6.03, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in China. Total returns to shareholders of 20% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥9.05 per share. Buy Or Sell Opportunity • Jan 30
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.2% to CN¥7.33. The fair value is estimated to be CN¥9.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings are forecast to grow by 162% in the next 2 years. Buying Opportunity • Jan 17
Now 21% undervalued Over the last 90 days, the stock is up 6.6%. The fair value is estimated to be CN¥9.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 162% in the next 2 years. Announcement • Dec 29
Shenzhen Noposion Crop Science Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Shenzhen Noposion Crop Science Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 Price Target Changed • Dec 21
Price target increased by 9.8% to CN¥12.27 Up from CN¥11.17, the current price target is an average from 2 analysts. New target price is 51% above last closing price of CN¥8.13. Stock is up 55% over the past year. The company is forecast to post earnings per share of CN¥0.43 for next year compared to CN¥0.34 last year. Reported Earnings • Aug 24
Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.16 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.12 (down from CN¥0.16 in 2Q 2022). Revenue: CN¥1.20b (down 11% from 2Q 2022). Net income: CN¥119.4m (down 23% from 2Q 2022). Profit margin: 9.9% (down from 12% in 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 28
First quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.17 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.17 in 1Q 2022). Revenue: CN¥1.35b (up 5.6% from 1Q 2022). Net income: CN¥218.4m (up 32% from 1Q 2022). Profit margin: 16% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥8.10, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years. Reported Earnings • Mar 01
Full year 2022 earnings released: EPS: CN¥0.34 (vs CN¥0.34 in FY 2021) Full year 2022 results: EPS: CN¥0.34. Revenue: CN¥4.26b (down 5.3% from FY 2021). Net income: CN¥327.8m (up 7.4% from FY 2021). Profit margin: 7.7% (up from 6.8% in FY 2021). The increase in margin was driven by lower expenses. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥6.95, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in China. Total loss to shareholders of 2.8% over the past three years. Price Target Changed • Nov 16
Price target decreased to CN¥7.76 Down from CN¥11.25, the current price target is provided by 1 analyst. New target price is 37% above last closing price of CN¥5.68. Stock is down 0.7% over the past year. The company is forecast to post earnings per share of CN¥0.34 for next year compared to CN¥0.34 last year. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Supervisor and Chairman of the Supervisory Board Mingzhang Cao was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Board Change • Nov 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Supervisor and Chairman of the Supervisory Board Mingzhang Cao was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 28
Third quarter 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.031 profit in 3Q 2021) Third quarter 2022 results: CN¥0.02 loss per share (down from CN¥0.031 profit in 3Q 2021). Revenue: CN¥580.5m (down 17% from 3Q 2021). Net loss: CN¥19.2m (down 170% from profit in 3Q 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Board Change • Oct 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Supervisor and Chairman of the Supervisory Board Mingzhang Cao was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Aug 20
Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.16 (down from CN¥0.17 in 2Q 2021). Revenue: CN¥1.35b (down 2.5% from 2Q 2021). Net income: CN¥155.2m (flat on 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 2% per year. Announcement • Jun 02
Shenzhen Noposion Agrochemicals Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2022 Shenzhen Noposion Agrochemicals Co.,Ltd announced 2021 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 2.00000000. Record date: 07 June 2022, Ex-date: 08 June 2022, Payment date: 08 June 2022. 10% withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable. Please refer to below details: Tax on cash dividend/10 shares: CNY 0.20000000(10% x CNY 2.00000000) Net cash dividend/10 shares after tax: CNY1.80000000(CNY2.00000000- CNY0.20000000). Announcement • May 31
Shenzhen Noposion Agrochemicals Co.,Ltd Approves Cash Dividend for 2021 Shenzhen Noposion Agrochemicals Co.,Ltd approves cash dividend of CNY 2.00000000 (tax included) per 10 shares for 2021. Announcement • Apr 28
Shenzhen Noposion Agrochemicals Co.,Ltd Proposes Final Cash Dividend for the Year 2021 Shenzhen Noposion Agrochemicals Co.,Ltd proposed final cash dividend (tax included) of CNY 2.00000 per 10 shares for the year 2021. Reported Earnings • Apr 28
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.17 (up from CN¥0.16 in 1Q 2021). Revenue: CN¥1.27b (up 4.5% from 1Q 2021). Net income: CN¥165.7m (up 12% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Reported Earnings • Feb 27
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥0.32 (up from CN¥0.19 in FY 2020). Revenue: CN¥4.49b (up 8.7% from FY 2020). Net income: CN¥291.5m (up 75% from FY 2020). Profit margin: 6.5% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.031 (vs CN¥0.017 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥697.9m (down 12% from 3Q 2020). Net income: CN¥27.4m (up 110% from 3Q 2020). Profit margin: 3.9% (up from 1.7% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥6.47, the stock trades at a trailing P/E ratio of 31.6x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 18% over the past three years. Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.16 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.38b (up 2.6% from 2Q 2020). Net income: CN¥155.5m (up 9.3% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.14 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.22b (up 3.0% from 1Q 2020). Net income: CN¥147.7m (up 13% from 1Q 2020). Profit margin: 12% (up from 11% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Announcement • Mar 09
Shenzhen Noposion Agrochemicals Co.,Ltd to Report Fiscal Year 2020 Results on Apr 23, 2021 Shenzhen Noposion Agrochemicals Co.,Ltd announced that they will report fiscal year 2020 results on Apr 23, 2021 Reported Earnings • Mar 04
Full year 2020 earnings released: EPS CN¥0.20 (vs CN¥0.26 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥4.14b (up 2.1% from FY 2019). Net income: CN¥180.8m (down 23% from FY 2019). Profit margin: 4.4% (down from 5.8% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Announcement • Jan 28
Shenzhen Noposion Agrochemicals Co.,Ltd(XSEC:002215) dropped from S&P Global BMI Index Shenzhen Noposion Agrochemicals Co.,Ltd(XSEC:002215) dropped from S&P Global BMI Index Is New 90 Day High Low • Jan 25
New 90-day low: CN¥5.19 The company is down 14% from its price of CN¥6.05 on 27 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥5.65 The company is down 8.0% from its price of CN¥6.14 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 22
New 90-day low: CN¥5.85 The company is down 7.0% from its price of CN¥6.32 on 23 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Oct 31
New 90-day low: CN¥5.87 The company is down 10.0% from its price of CN¥6.51 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥259.1m, down 12% from the prior year. Total revenue was CN¥4.16b over the last 12 months, up 1.6% from the prior year. Announcement • Oct 20
Shenzhen Noposion Agrochemicals Co.,Ltd to Report Q3, 2020 Results on Oct 28, 2020 Shenzhen Noposion Agrochemicals Co.,Ltd announced that they will report Q3, 2020 results on Oct 28, 2020 Announcement • Aug 07
Shenzhen Noposion Agrochemicals Co.,Ltd to Report First Half, 2020 Results on Aug 26, 2020 Shenzhen Noposion Agrochemicals Co.,Ltd announced that they will report first half, 2020 results on Aug 26, 2020 Announcement • Aug 06
Shenzhen Noposion Agrochemicals Co.,Ltd (SZSE:002215) agreed to acquire remaining 0.98% in Shaanxi Biaozheng Crop Technology Co., Ltd. from Lu Lihong for CNY 2.2 million. Shenzhen Noposion Agrochemicals Co.,Ltd (SZSE:002215) agreed to acquire remaining 0.98% in Shaanxi Biaozheng Crop Technology Co., Ltd. from Lu Lihong for CNY 2.2 million on July 30, 2020. The consideration will be paid in cash. Post completion, Shenzhen Noposion Agrochemicals Co.,Ltd will hold 100% in Shaanxi Biaozheng Crop Technology Co., Ltd. For the year ended December 31, 2019, Shaanxi Biaozheng Crop Technology Co., Ltd. reported total assets of CNY 395.2 million, revenues of CNY 207.5 million, net income of CNY 22.3 million and net assets of CNY 214.8 million. The Board of Directors of Shenzhen Noposion Agrochemicals Co.,Ltd approved the deal on July 30, 2020. The deal does not require approval from shareholders. Announcement • Aug 04
Shenzhen Noposion Agrochemicals Co.,Ltd announced that it expects to receive CNY 530.18 million in funding Shenzhen Noposion Agrochemicals Co., Ltd. (SZSE:002215) announced a private placement of not more than 274,222,915 domestically listed class A ordinary common shares for not more than CNY 530,180,000 on July 30, 2020. The pricing base date for the transaction will be the first day of the issue period, and the issue price is not less than 80% of the average price of the company's stocks 20 trading days before the first day of the issue period. The maximum number of non-publicly issued shares shall not exceed 30% of the company's total share capital before the issuance. The transaction will include participation from not more than 35 special investors. The transaction has been approved by 20th meeting of the 5th directorate of the company and is subject to the approval of its shareholders meeting and the China Securities Regulatory Commission. The shares are subject to a lock-up period of 6 months and will be listed and traded on the Shenzhen stock exchange market.